Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 1.00 |
| ▸ | F10 | P00742 | 1/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 9/20 | 0.85 |
| ▸ | PRKCG | P05129 | 9/20 | 0.85 |
| ▸ | PRKCB | P05771 | 9/20 | 0.85 |
| ▸ | PRKCA | P17252 | 9/20 | 0.85 |
| ▸ | PRKCH | P24723 | 9/20 | 0.85 |
| ▸ | PRKCI | P41743 | 9/20 | 0.85 |
| ▸ | PRKCE | Q02156 | 9/20 | 0.85 |
| ▸ | PRKCQ | Q04759 | 9/20 | 0.85 |
| ▸ | PRKCZ | Q05513 | 9/20 | 0.85 |
| ▸ | PRKCD | Q05655 | 9/20 | 0.85 |
| ▸ | PRKD1 | Q15139 | 9/20 | 0.85 |
| ▸ | RAD52 | P43351 | 2/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tellimagrandin Ii SCHEMBL29369707 | 1.00 | BACE1 (1.00) | BACE1F10PRKD3PRKCGPRKCB | |
| Eugeniin SCHEMBL618555 | 1.00 | BACE1 (1.00) | BACE1F10PRKD3PRKCGPRKCB | |
| Hirtellin A SCHEMBL30515194 | 0.95 | BACE1 (0.91) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL15280903 | 0.93 | BACE1 (0.87) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL10021533 | 0.93 | BACE1 (0.86) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL16802809 | 0.93 | BACE1 (0.86) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL9999979 | 0.93 | BACE1 (0.86) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL12824705 | 0.92 | BACE1 (0.85) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL21566460 | 0.92 | BACE1 (0.85) | BACE1F10PRKD3PRKCGPRKCB | |
| SCHEMBL30385544 | 0.92 | BACE1 (0.85) | BACE1F10PRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027269-A1 | OSTOMY BAG WITH A SLIPPERY SURFACE | PENN STATE RES FOUND (US) | 2026-01-29 | — | — | US | claimed |
| US-12419997-B2 | Ostomy bag with a slippery surface | THE PENN STATE RESEARCH FOUNDATION (PA) | 2025-09-23 | — | — | US | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230276836-A1 | ORAL RETENTION COMPOSITION | BIZEN CHEMICAL CO., LTD. (JP) | 2023-09-07 | — | — | US | claimed |
| US-20230043198-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | YALE UNIVERSITY (US) | 2023-02-09 | — | — | US | claimed |
| US-20220047615-A1 | Immune Supplement Composition | LOCUS OIL HOLDING, LLC, | 2022-02-17 | — | — | US | claimed |
| US-20220015406-A1 | Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder | FLAASK, LLC. | 2022-01-20 | — | — | US | claimed |
| EP-3893941-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | Yale University (US) | 2021-10-20 | — | — | EP | claimed |
| US-20210236529-A1 | MULTI-TARGETED COMPOSITIONS FOR MITIGATING ACUTE RESPIRATORY DISTRESS SYNDROME | SYTHEON LTD (US) | 2021-08-05 | — | — | US | claimed |
| US-20210052784-A1 | OSTOMY BAG WITH A SLIPPERY SURFACE | NATIONAL SCIENCE FOUNDATION | 2021-02-25 | — | — | US | claimed |
| WO-2010143058-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE | GENEREX PHARMACEUTICALS, INC. (CN) | 2010-12-16 | — | — | WO | claimed |
| WO-2009114810-A2 | USE OF ELLAGITANNINS AS INHIBITORS OF BACTERIAL QUORUM SENSING | THE FLORIDA INTERNATIONAL UINVERSITY BOARD OF TRUSTEES (US) | 2009-09-17 | — | — | WO | claimed |
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | claimed |
| US-20080070850-A1 | GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-03-20 | — | — | US | claimed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | claimed |
| WO-2007133479-A2 | DELIVERY OF ELASTIN-STABILIZING COMPOUND WITHIN A BODY LUMEN | COOK INCORPORATED (US) | 2007-11-22 | — | — | WO | claimed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | claimed |
| CN-1425021-A | Gallotannins and ellagitannins as modulators of cytokine release | PENN STATE RES FOUND (US) | 2003-06-18 | — | — | CN | claimed |
| EP-1232169-A1 | GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-08-21 | — | — | EP | claimed |
| WO-2001036436-A1 | GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE | THE PENN STATE RESEARCH FOUNDATION (US) | 2001-05-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070850-A1 | GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE | IL2, IL6, TNF | BACE1 3072/4885F10 885/4885PRKD3 3808/4885 |
| US-20260027269-A1 | OSTOMY BAG WITH A SLIPPERY SURFACE | OSTC, SORD, STOM | BACE1 3835/4885F10 1010/4885PRKD3 2909/4885 |
| US-20220015406-A1 | Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder | FABP2, MAG, FABP7 | BACE1 2114/4885F10 4282/4885PRKD3 3017/4885 |
| US-20220047615-A1 | Immune Supplement Composition | HAVCR2, ST14, CD14 | BACE1 1147/4885F10 4316/4885PRKD3 2656/4885 |
| US-20210236529-A1 | MULTI-TARGETED COMPOSITIONS FOR MITIGATING ACUTE RESPIRATORY DISTRESS SYNDROME | ACE2, TMPRSS2, MAVS | BACE1 1641/4885F10 4574/4885PRKD3 3217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.